Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

MiniMax made a stellar stock market debut in Hong Kong on Friday, with shares more than doubling as investors continued to pile into Chinese artificial-intelligence start-ups.

MiniMax shares doubled in Hong Kong debut, beating rival Zhipu AI’s first-day gains. The IPO highlights China’s race to fund homegrown AI firms despite U.S. curbs on advanced chips. Rapid user growth ...

eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...

MiniMax Unveils M2.1 to Bring Multilingual Programming Gains to Open AI Models Your email has been sent Chinese AI startup’s release is a major update to its open-source model series, aimed at ...

What if the next big leap in AI wasn’t locked behind corporate paywalls but was instead freely available for anyone to explore, adapt, and innovate with? That’s exactly the promise of MiniMax M2.1, ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Recursion Pharmaceuticals developed a promising artificial intelligence (AI) platform for drug discovery and development. The company's clinical-stage pipeline is just the tip of the iceberg of its ...